Hao‐Xiang Wu
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response(2022)269 cited
- → Advancing to the era of cancer immunotherapy(2021)208 cited
- → Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer(2021)179 cited
- → Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers(2019)131 cited
- → Nestin regulates cellular redox homeostasis in lung cancer through the Keap1–Nrf2 feedback loop(2019)125 cited
- → Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers(2019)118 cited
- → ERK/Drp1-dependent mitochondrial fission is involved in the MSC-induced drug resistance of T-cell acute lymphoblastic leukemia cells(2016)116 cited
- → Neoadjuvant Programmed Cell Death 1 (PD-1) Inhibitor Treatment in Patients With Hepatocellular Carcinoma Before Liver Transplant: A Cohort Study and Literature Review(2021)85 cited
- → Clinical Benefit of First-Line Programmed Death-1 Antibody Plus Chemotherapy in Low Programmed Cell Death Ligand 1–Expressing Esophageal Squamous Cell Carcinoma: A Post Hoc Analysis of JUPITER-06 and Meta-Analysis(2022)71 cited
- → EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers(2021)65 cited